Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

24 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

vismodegib Articles

Faster-than-expected FDA approval of Roche’s vismodegib

31 January 2012

FDA priority review for Roche/Genentech’s vismodegib for skin cancer

10 November 2011

Genentech files with US FDA for vismodegib in rare form of advanced skin cancer

13 September 2011

Positive mid-stage data on Roche and Curis' BCC drug vismodegib

22 June 2011

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Is the diabetes market facing a blockbuster-free future?
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Is the diabetes market facing a blockbuster-free future?
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS